Recruiting
Phase 1
Phase 2

177LuBetaBart

Sponsor:

Radiopharm Theranostics, Ltd

Code:

NCT07189871

Conditions

Castration-Resistant Prostate Cancer (CRPC)

Colorectal Cancer

NSCLC (Non-small Cell Lung Cancer)

Ovarian Cancer

Cervical Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

177Lu-BetaBart

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-01-19. This information was provided to ClinicalTrials.gov by Radiopharm Theranostics, Ltd on 2026-01-15.